Btk inhibitors in atherosclerosis
In this issue of Blood , Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques. 1
Gespeichert in:
| Veröffentlicht in: | Blood 2018-06, Vol.131 (24), p.2601-2602 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2602 |
|---|---|
| container_issue | 24 |
| container_start_page | 2601 |
| container_title | Blood |
| container_volume | 131 |
| creator | Lindner, Jonathan R. |
| description | In this issue of
Blood
,
Busygina et al
provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.
1 |
| doi_str_mv | 10.1182/blood-2018-04-841916 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6032894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120321522</els_id><sourcerecordid>2056397352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-be883bb32c648c48b17aa34a57144e7aead52cb75c2905d8f8bbc271136610743</originalsourceid><addsrcrecordid>eNp9kEtPAjEQxxujEUS_gTF487I6fXcvJkp8JSRe9Ny03SLVZYvtQuK3dxFEvXiZmczjPzM_hI4xnGOsyIWtY6wKAlgVwArFcInFDupjTroEENhFfQAQBSsl7qGDnF8BMKOE76MeKUugSsg-Or1u34ahmQYb2phyFw5NO_UpZlevbMiHaG9i6uyPNn6Anm9vnkb3xfjx7mF0NS4cE7QtrFeKWkuJE0w5piyWxlBmuMSMeWm8qThxVnJHSuCVmihrHZEYUyEwSEYH6HKtO1_Yma-cb9pkaj1PYWbSh44m6L-VJkz1S1xqAZSociVwthFI8X3hc6tnITtf16bxcZE1AS5oKSknXStbt7ruxZz8ZLsGg17R1V909YquBqbXdLuxk98nboe-cf784DtQy-CTzi74xvkqJO9aXcXw_4ZPG2mLlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2056397352</pqid></control><display><type>article</type><title>Btk inhibitors in atherosclerosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Lindner, Jonathan R.</creator><creatorcontrib>Lindner, Jonathan R.</creatorcontrib><description>In this issue of
Blood
,
Busygina et al
provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.
1</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2018-04-841916</identifier><identifier>PMID: 29903867</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Agammaglobulinaemia Tyrosine Kinase ; Atherosclerosis ; Humans ; Plaque, Atherosclerotic ; Protein Kinase Inhibitors ; Thrombosis</subject><ispartof>Blood, 2018-06, Vol.131 (24), p.2601-2602</ispartof><rights>2018 American Society of Hematology</rights><rights>2018 by The American Society of Hematology 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-be883bb32c648c48b17aa34a57144e7aead52cb75c2905d8f8bbc271136610743</citedby><cites>FETCH-LOGICAL-c463t-be883bb32c648c48b17aa34a57144e7aead52cb75c2905d8f8bbc271136610743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29903867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindner, Jonathan R.</creatorcontrib><title>Btk inhibitors in atherosclerosis</title><title>Blood</title><addtitle>Blood</addtitle><description>In this issue of
Blood
,
Busygina et al
provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.
1</description><subject>Agammaglobulinaemia Tyrosine Kinase</subject><subject>Atherosclerosis</subject><subject>Humans</subject><subject>Plaque, Atherosclerotic</subject><subject>Protein Kinase Inhibitors</subject><subject>Thrombosis</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtPAjEQxxujEUS_gTF487I6fXcvJkp8JSRe9Ny03SLVZYvtQuK3dxFEvXiZmczjPzM_hI4xnGOsyIWtY6wKAlgVwArFcInFDupjTroEENhFfQAQBSsl7qGDnF8BMKOE76MeKUugSsg-Or1u34ahmQYb2phyFw5NO_UpZlevbMiHaG9i6uyPNn6Anm9vnkb3xfjx7mF0NS4cE7QtrFeKWkuJE0w5piyWxlBmuMSMeWm8qThxVnJHSuCVmihrHZEYUyEwSEYH6HKtO1_Yma-cb9pkaj1PYWbSh44m6L-VJkz1S1xqAZSociVwthFI8X3hc6tnITtf16bxcZE1AS5oKSknXStbt7ruxZz8ZLsGg17R1V909YquBqbXdLuxk98nboe-cf784DtQy-CTzi74xvkqJO9aXcXw_4ZPG2mLlg</recordid><startdate>20180614</startdate><enddate>20180614</enddate><creator>Lindner, Jonathan R.</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180614</creationdate><title>Btk inhibitors in atherosclerosis</title><author>Lindner, Jonathan R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-be883bb32c648c48b17aa34a57144e7aead52cb75c2905d8f8bbc271136610743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Agammaglobulinaemia Tyrosine Kinase</topic><topic>Atherosclerosis</topic><topic>Humans</topic><topic>Plaque, Atherosclerotic</topic><topic>Protein Kinase Inhibitors</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindner, Jonathan R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindner, Jonathan R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Btk inhibitors in atherosclerosis</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2018-06-14</date><risdate>2018</risdate><volume>131</volume><issue>24</issue><spage>2601</spage><epage>2602</epage><pages>2601-2602</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>In this issue of
Blood
,
Busygina et al
provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.
1</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29903867</pmid><doi>10.1182/blood-2018-04-841916</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2018-06, Vol.131 (24), p.2601-2602 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6032894 |
| source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library |
| subjects | Agammaglobulinaemia Tyrosine Kinase Atherosclerosis Humans Plaque, Atherosclerotic Protein Kinase Inhibitors Thrombosis |
| title | Btk inhibitors in atherosclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A17%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Btk%20inhibitors%20in%20atherosclerosis&rft.jtitle=Blood&rft.au=Lindner,%20Jonathan%20R.&rft.date=2018-06-14&rft.volume=131&rft.issue=24&rft.spage=2601&rft.epage=2602&rft.pages=2601-2602&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2018-04-841916&rft_dat=%3Cproquest_pubme%3E2056397352%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2056397352&rft_id=info:pmid/29903867&rft_els_id=S0006497120321522&rfr_iscdi=true |